Key result
MKP-1 overexpression prevents agonist-induced cardiac hypertrophy and diminishes developmental myocardial growth.
Answers are grounded in this paper and cite their sources.
Shows that MKP-1 expression suppresses MAPK signaling and prevents cardiac hypertrophy in cardiomyocyte and mouse models, indicating a critical regulatory role in limiting abnormal heart growth.
Mitogen-activated protein kinase (MAPK) signaling pathways are important regulators of cell growth, proliferation, and stress responsiveness. A family of dual-specificity MAP kinase phosphatases (MKPs) act as critical counteracting factors that directly regulate the magnitude and duration of p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) activation. Here we show that constitutive expression of MKP-1 in cultured primary cardiomyocytes using adenovirus-mediated gene transfer blocked the activation of p38, JNK1/2, and ERK1/2 and prevented agonist-induced hypertrophy. Transgenic mice expressing physiological levels of MKP-1 in the heart showed (1) no activation of p38, JNK1/2, or ERK1/2; (2) diminished developmental myocardial growth; and (3) attenuated hypertrophy in response to aortic banding and catecholamine infusion. These results provide further evidence implicating MAPK signaling factors as obligate regulators of cardiac growth and hypertrophy and demonstrate the importance of dual-specificity phosphatases as counterbalancing regulatory factors in the heart.
No takes yet. Share an insight, caveat, or question.
Bueno et al. (2001) studied Cardiac Hypertrophy. Constitutive expression of MKP-1 was evaluated on Cardiac hypertrophy and MAPK signaling activation. Constitutive expression of MKP-1 in cultured cardiomyocytes and transgenic mice prevented agonist-induced hypertrophy and diminished developmental myocardial growth.
Synapse has enriched 10 related papers. Consider them for comparative context: